A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women - PubMed
pubmed.ncbi.nlm.nih.gov
Aspirin's antithrombotic effect is mediated predominately by inhibition of platelet cyclooxygenase-1, leading to a decline in serum thromboxane A2 concentrations. We performed a placebo-controlled, randomized, double-blind trial to determine whether aspirin could be given at 3-day intervals and stil …